Table 1 Astrocytic expression of P2ry1/P2RY1 and Igfbp2/IGFBP2 in neurological disease models in publicly available datasets
GEO accession | Organism | Disease model | Experiment type | Comparison | Gene expression | |||
|---|---|---|---|---|---|---|---|---|
P2ry1/P2RY1 | Igfbp2/IGFBP2 | |||||||
Log2FoldChange | FDR | Log2FoldChange | FDR | |||||
GSE183050 | Mus muscles | Alzheimer’s disease model | RNA-seq | APPPS1::APOE4fl/fl::ALDH1L1-CreERT vs APPPS1::APOE4fl/fl | −0.28 | 0.99 | −0.47 | 0.96 |
GSE183050 | Mus muscles | Alzheimer’s disease model | RNA-seq | APOE4fl/fl::ALDH1L1-CreERT vs APPPS1::APOE4fl/fl::ALDH1L1-CreERT | 0.47 | 0.95 | 0.80 | 0.90 |
GSE129797 | Mus muscles | Alzheimer’s disease model | RNA-seq | WT vs Tau-P301S | −0.30 | 0.76 | −2.4 | 0.18 |
GSE138695 | Homo sapience | Alzheimer’s disease | RNA-seq | Ctrl vs AD4 | 0.70 | 2 × 10−6 | 0.19 | 0.063 |
GSE138695 | Homo sapience | Alzheimer’s disease | RNA-seq | Ctrl vs AD5 | 1.13 | 1 × 10−14 | 0.13 | 0.22 |
GSE191131 | Mus muscles | Parkinson’s disease model | RNA-seq | WT vs parkinsonian | 0.29 | 0.97 | −0.085 | 0.98 |
GSE103782 | Mus muscles | Stroke model | RNA-seq | Ctrl vs MCAO | 0.72 | 0.59 | −0.77 | 0.46 |